Skip to main content
EJVES Vascular Forum logoLink to EJVES Vascular Forum
. 2026 Oct 15;66:141–145. doi: 10.1016/j.ejvsvf.2026.10.003

Non-reconstruction Radical Resection Strategy for Inferior Vena Cava Leiomyosarcoma

Jialing Liu 1, Jiechang Zhu 1,⁎, Guangze Luo 1
PMCID: PMC13781613  PMID: 43060395

Abstract

Introduction

Leiomyosarcoma of the inferior vena cava (IVCL) is a clinically rare malignancy characterised by late onset symptoms, diagnostic challenges, and a high recurrence rate. Surgery is the only curative treatment, but whether reconstruction is necessary remains debated.

Report

Three elderly patients (mean age 70 ± 3 years) with IVCL underwent radical resection without IVC reconstruction. All of them had a well established collateral circulation, confirmed by pre-operative contrast enhanced computed tomography and magnetic resonance imaging, and intra-operative haemodynamic stability. The patients all underwent R0 resection with preserved renal function and without peri-operative death. One patient with tumour extending to the retrohepatic IVC underwent tumour resection under cardiopulmonary bypass to prevent pulmonary embolism; she developed liver metastases at nine months but had stable disease with multimodal therapy at the 37 month follow up. The other two were disease free at 24 and three months.

Discussion

IVC resection with a planned non-reconstruction strategy is safe and feasible in selected elderly patients with well developed collateral circulation, avoiding graft related complications and long term anticoagulation. Meticulous imaging evaluation and multidisciplinary assessment of the collateral circulation are crucial for individualised decision making.

Keywords: Diagnostic imaging, Inferior vena cava, Leiomyosarcoma, Multidisciplinary collaboration, Non-reconstruction

HIGHLIGHTS

  • •

    Three elderly IVC leiomyosarcoma patients had non-reconstruction resection.

  • •

    Collateral circulation was confirmed by imaging and intra-operative haemodynamics.

  • •

    All patients had R0 resection with preserved renal function and no mortality.

  • •

    Non-reconstruction avoids graft complications and long term anticoagulation.

  • •

    Collateral assessment is crucial for patient selection and surgical.

INTRODUCTION

First described by Perl in 1871,1 leiomyosarcoma of the inferior vena cava (IVCL) is a rare malignant tumour originating from venous smooth muscle cells and representing the most common primary malignancy of the inferior vena cava (IVC).2 It predominantly affects middle aged women. Due to its deep retroperitoneal location and proximity to critical structures, including the hepatic veins, renal veins, and the right atrium, clinical manifestations are non-specific, often leading to misdiagnosis. The lesion can be divided into three types based on its location relative to the hepatic and renal veins: type I – the segment of the IVC below the renal veins; type II – between the hepatic and renal veins; and type III – above the hepatic veins.3 Surgery remains the cornerstone of curative treatment, with chemoradiation playing a secondary role.2, 4 However, whether IVC reconstruction is necessary after radical resection remains debated. This report retrospectively analysed three elderly patients diagnosed with IVCL between November 2021 and December 2025, focusing on the feasibility of a planned non-reconstruction strategy.

REPORT

Case 1

A 67 year old woman presented with right upper quadrant abdominal pain. Abdominal contrast enhanced computed tomography (CT) showed a large mixed density IVC mass (65 × 86 mm) extending from the retrohepatic segment to the confluence of the IVC. The tumour involved the right renal vein. The borders of the mass were indistinct from the pancreas and right adrenal gland (type I + II) (Fig. 1A and B).3 Given the well developed collateral circulation on pre-operative imaging (primary collateral vein diameter ≥ 10 mm), a planned non-reconstruction strategy was adopted. Laparoscopic retroperitoneal biopsy confirmed a mesenchymal tumour. Two months later, the tumour was progressing.

Figure 1.

Figure 1

Case 1 images. (A) Pre-operative contrast enhanced computed tomography (CT) showing the inferior vena cava (IVC) sarcoma (white arrow) involving the hepatic veins. (B) The tumour (white arrow) extends from the retrohepatic segment down to the caval confluence. (C) Intra-operative cannulation of the right atrium for blood re-infusion (yellow arrow) and control of the infrahepatic IVC at the cavo-atrial junction (green arrow). (D) Post-resection field showing a T tube drain, right sided thoracic closed drain, and abdominal drain in situ.

The resection was undertaken via a right thoraco-abdominal incision. Intra-operative exploration revealed that the IVCL extended superiorly to the second hepatic portal and inferiorly to the caval confluence. The infrahepatic IVC was controlled at the junction to the right atrium (Fig. 1C). The porta hepatis was encircled to reduce the bleeding during IVC incision. Cannulation of the right atrium was performed for blood re-infusion. When the infrahepatic IVC was incised, retrograde bleeding from the hepatic veins was retrieved into the bypass circuit, and the proximal tumour thrombus was extracted. Subsequently, the IVC was transected at a point distal to the retrohepatic segment of the IVC. The remaining caval stump was closed. En bloc resection of the involved IVC, right kidney, right adrenal gland, gallbladder, and third and fourth portions of the duodenum was performed. The left renal vein was divided and ligated at its origin. IVC reconstruction was not performed. A T tube drain, right sided thoracic closed drainage, and abdominal drainage were placed (Fig. 1D).

Post-operative pathological examination confirmed IVCL. An abdominal CT scan at three months post-operation showed no recurrence. However, subsequent abdominal magnetic resonance imaging (MRI) showed that liver metastases had appeared nine months post-operation. Thus, the patient received niraparib tosylate treatment together with interventional procedures targeting the metastatic lesions. The rationale for selecting this specific agent was not documented in the available medical records, as subsequent oncological treatment decisions were made by the medical oncology team. One and a half years after the surgery, an ultrasound guided biopsy of a hepatic mass confirmed metastatic leiomyosarcoma. Subsequently, transarterial chemo-embolisation and multiple sessions of hepatic arterial infusion chemotherapy were performed. At the most recent follow up, 37 months post-operation, the patient's condition remained stable.

Case 2

A 73 year old asymptomatic woman was admitted following the incidental discovery of an IVC mass. Abdominal enhanced MRI revealed a soft tissue mass (44 × 42 × 73 mm) within the IVC, extending from subhepatic IVC to the level of the right renal hilum. The borders of the mass were indistinct from the right adrenal and right renal hilar vessels (Fig. 2A). The tumour was definitively located in the segment of the IVC between the hepatic and renal veins (type II).3 Given the well developed collateral circulation on pre-operative imaging (primary collateral vein diameter ≥ 10 mm), a planned non-reconstruction strategy was adopted. The resection was undertaken via a right sided thoraco-abdominal incision (Fig. 2B). Intra-operative exploration identified the tumour within the infrahepatic IVC, with its inferior border located above the level of the renal veins. The IVC was clamped proximal and distal to the tumour, then en bloc resection was performed (Fig. 2C). After tumour removal, haemodynamic stability was observed. The two ends of the IVC were closed and no vascular reconstruction was performed (Fig. 2D). Post-operative pathology confirmed IVCL. The patient received adjuvant chemotherapy two months after surgery. The specific regimen and indications were determined by the medical oncology team and were not fully available for review. A follow up abdominal contrast enhanced CT scan two years post-operation showed no signs of tumour recurrence.

Figure 2.

Figure 2

Case 2 images. (A) Pre-operative contrast enhanced magnetic resonance imaging (MRI) showing an intracaval soft tissue mass (white arrow) within the inferior vena cava (IVC), extending from the subhepatic IVC to the level of the right renal hilum. (B) Right sided thoraco-abdominal incision through the seventh intercostal space, extending along the lateral border of the right rectus abdominis to below the umbilicus. (C) Intra-operative photograph showing control of the IVC proximal and distal to the tumour (white arrows) before resection. (D) Surgical field following en bloc tumour resection, showing the remaining superior and inferior caval stumps. No vascular reconstruction was performed.

Case 3

A 70 year old woman was admitted to the hospital with an abdominal mass. She had a history of mitral valve replacement and radiofrequency ablation for atrial fibrillation. She was on long term oral anticoagulation. Enhanced abdominal contrast enhanced CT revealed an irregular mass (50 × 41 × 40 mm) within the IVC extending from below the liver to the pelvis (type I and II) (Fig. 3A).3 Given the well developed collateral circulation on pre-operative imaging (primary collateral vein diameter ≥ 10 mm), a planned non-reconstruction strategy was adopted. Positron emission tomography CT revealed an elongated, irregular soft tissue mass along the right side of the IVC. The resection was undertaken via a right paramedian incision. Intra-operative exploration revealed that the tumour invaded the right kidney and the third part of the duodenum. It originated from the right ovarian vein, extending superiorly to below the liver and inferiorly to below the renal veins (Fig. 3B). En bloc resection was performed, including the involved segment of the IVC, the right ovarian vein, the right kidney, and part of the intestinal wall of the involved duodenum (Fig. 3C, 3D). After confirming adequate collateral circulation, the IVC was not reconstructed. Post-operative pathology confirmed the diagnosis of IVCL, with invasion into the duodenal muscular layer and renal vein. Follow up three months post-operation showed no signs of tumour recurrence.

Figure 3.

Figure 3

Case 3 images. (A) Pre-operative contrast enhanced computed tomography (CT) showing an irregular intracaval mass (white arrow) within the inferior vena cava (IVC), extending from below the liver to the pelvis. (B) Intra-operative photograph showing the tumour originating from the right ovarian vein (white arrow). The infrarenal IVC is normal. (C) Intra-operative photograph showing the IVC sarcoma (white arrow) arising from the ovarian vein and extending from below the liver to the infrarenal cava. (D) Gross specimen following en bloc resection, including the involved segment of the IVC.

DISCUSSION

IVCL is a rare retroperitoneal malignancy. It predominantly affects women, with a reported mean age at onset of 55.4 ± 13.0 years2, 3 although these three patients had a mean age of 70 ± 3 years. Patients frequently present with non-specific symptoms. IVCL grows slowly, and collateral circulation often develops as the tumour occludes the caval lumen, making early diagnosis challenging.

Imaging is central to the non-reconstruction strategy. All patients underwent contrast enhanced CT or MRI with venous phase sequences to clearly show tumour extent and assess collateral venous pathways, including the ascending lumbar veins, azygos and the hemiazygos systems, and gonadal and adrenal veins.2, 3 These scans typically reveal a chronically occluded or severely narrowed vena cava with extensive collateral circulation.2 When such well developed collaterals are present, several authors have suggested that vascular reconstruction can safely be avoided.5 From current experience, the collateral circulation was considered adequate when the primary collateral veins measured at least 10 mm in diameter on pre-operative imaging, a threshold based on local clinical practice. This imaging based assessment guided the intra-operative decision to avoid reconstruction.

Radical surgical resection is the cornerstone of treatment and the basis for long term survival. Kulaylat and Hilliard et al. indicated that en bloc resection may be the only potentially curative modality for IVCL, far more significant than adjuvant therapy.6, 7 This principle was applied in all three cases in this series, where all three patients had a well established collateral circulation. Chzhao et al. reported that vascular reconstruction is unnecessary after resecting the affected caval segment when the collateral circulation is adequate.5 This approach reduces the long term risks associated with prosthetic grafts, such as infection, thrombosis, and anticoagulation.8 The left renal vein possesses abundant collaterals (gonadal, adrenal veins), enabling most patients to tolerate ligation. These three patients maintained normal renal function, validating the safety and efficacy of this strategy. In contrast, Tulahong et al. advocated IVC reconstruction to restore physiological venous return.9 However, several factors, including reduced surgical tolerance in the elderly, higher comorbidity prevalence, and long term risks of prosthetic implants, led non-reconstruction to be favoured when the collateral circulation was adequate.

If the tumour has local invasion, radical resection should be performed as thoroughly as possible. Cases 1 and 3 underwent multivisceral resection including partial duodenectomy and right nephrectomy. Mastoraki et al. emphasised that en bloc resection is often necessary to achieve negative margins when the tumour invades surrounding organs.10 Although Wachtel et al. identified combined organ resection as a negative prognostic factor, positive surgical margins exert an even more detrimental impact.11

In Case 1, the tumour extended proximally to the level of the hepatic veins. Kulaylat et al. noted that tumour invasion of the hepatic veins presents a major surgical challenge, necessitating more complex strategies for vascular control.6 To ensure procedural safety and prevent tumour thrombus dislodgment leading to pulmonary embolism, right atrium cannulation was performed for blood re-infusion. This circuit was used to retrieve the substantial back bleeding from the hepatic veins. Additionally, the infrahepatic IVC was controlled at the cavo-atrial junction to control retrograde haemorrhage from the right atrium. Although the tumour involved the hepatic segment of the IVC, the root of the tumour was at a lower level. The critical surgical manoeuvre entailed an incision into the cava to extract the tumour thrombus, followed by complete resection of the involved segment, while preserving the hepatic venous return. Despite the occurrence of post-operative distant metastases in this case, this outcome was more likely to be attributable to the aggressive biology of the tumour than to the choice of surgical approach. This observation underscores the high propensity for recurrence and metastasis characteristic of IVCL.12 Wachtel et al. revealed a persistently high post-operative recurrence rate for this disease, with a five year disease free survival rate of approximately 8%.11 This patient subsequently received comprehensive treatment, including targeted therapy, local ablation, and hepatic arterial chemo-embolisation.

Graduated compression stockings were fitted for all three patients as per hospital protocol for DVT prophylaxis, and regular lower limb venous ultrasound surveillance was performed throughout the hospital stay. In Case 1, no anticoagulant was administered owing to a high bleeding risk following extensive multivisceral resection, and no thrombotic events were documented. Case 2 received dextran on day one and low molecular weight heparin (LMWH) from day three; a deep vein thrombosis (DVT) was detected on day seven and treated with therapeutic dose enoxaparin. On post-operative day 15, ultrasound showed no new thrombus formation or DVT progression, indicating that the thrombus remained stable. Case3 had a pre-existing DVT before surgery. Dextran was commenced on day one and LMWH on day three; a new left lower limb DVT was detected on day 13 and was monitored closely without additional anticoagulation. The DVT remained clinically stable at the time of discharge.

Multidisciplinary team (MDT) discussion was integral throughout treatment. Given the high recurrence probability, surgery alone is often insufficient. The course of Case 1 demonstrated that interventional and targeted therapy can effectively control lesions. For patients with complex comorbidities (Case 3), a multidisciplinary team approach improves surgical success.

Only Case 2 received adjuvant chemotherapy, following MDT discussion. Among the three patients, Case 2 presented with the most localised disease and underwent the most limited resection; the operating team considered that surgery combined with adjuvant therapy might offer a better oncological outcome. However, the specific chemotherapy regimen was determined by the medical oncology team and was not fully available for review. Case 1 developed early liver metastases and therefore received systemic therapy and locoregional treatments to control metastatic progression and prolong survival. Case 3 was still in the early post-operative period. The patient remains under regular follow up, and the need for adjuvant therapy will be further assessed as more follow up data become available.

While the MDT helped guide surgical management, the details of oncological care after discharge, as well as peri-operative anticoagulation records for one case, were not fully available, as subsequent management was coordinated by other specialty teams. This represents a limitation inherent to this retrospective report.

In summary, for elderly patients with confirmed adequate collateral circulation, a strategy prioritising radical resection while avoiding complex vascular reconstruction, followed by comprehensive multidisciplinary post-operative care, can achieve satisfactory clinical outcomes.

CONFLICT OF INTEREST AND FUNDING

None.

REFERENCES

  • 1.Keller K., Jacobi B., Jabal M., Stavrou G.A. Leiomyosarcoma of the inferior vena cava: a case report of a rare tumor entity. Int J Surg Case Rep. 2020;71:50–53. doi: 10.1016/j.ijscr.2020.04.094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Di Pilla M.A., Capuano M.A., Rossi M., Di Pilla G., Minelli R., Pizzicato P., et al. Leiomyosarcoma of the inferior vena cava. Radiol Case Rep. 2024;19:382–386. doi: 10.1016/j.radcr.2023.09.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Li F., Li C., Guo W., Meng X. A world-wide systematic review of the primary leiomyosarcoma of inferior vena cava. Asian J Surg. 2023;46:5983–5984. doi: 10.1016/j.asjsur.2023.09.018. [DOI] [PubMed] [Google Scholar]
  • 4.Kieffer E., Alaoui M., Piette J.C., Cacoub P., Chiche L. Leiomyosarcoma of the inferior vena cava: experience in 22 cases. Ann Surg. 2006;244:289–295. doi: 10.1097/01.sla.0000229964.71743.db. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chzhao A., Zotikov A., Karmazanovsky G., Gurmikov B., Ivandaev A. Leiomyosarcoma of the inferior vena cava. J Vasc Surg Cases Innov Tech. 2020;6:307–310. doi: 10.1016/j.jvscit.2020.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kulaylat M.N., Karakousis C.P., Doerr R.J., Karamanoukian H.L., O'Brien J., Peer R. Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol. 1997;65:205–217. doi: 10.1002/(sici)1096-9098(199707)65:3<205::aid-jso11>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  • 7.Hilliard N.J., Heslin M.J., Castro C.Y. Leiomyosarcoma of the inferior vena cava: three case reports and review of the literature. Ann Diagn Pathol. 2005;9:259–266. doi: 10.1016/j.anndiagpath.2005.05.001. [DOI] [PubMed] [Google Scholar]
  • 8.Bower T.C., Nagorney D.M., Cherry K.J., Jr., Toomey B.J., Hallett J.W., Panneton J.M., et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg. 2000;31:270–281. doi: 10.1016/s0741-5214(00)90158-7. [DOI] [PubMed] [Google Scholar]
  • 9.Tulahong A., Tuxun T., Yao G., Fulati X., Apaer S., Anweier N., et al. Surgical management strategy for leiomyosarcoma of zone I-II inferior vena cava: a case series. Medicine (Baltimore) 2022;101 doi: 10.1097/MD.0000000000029326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mastoraki A., Leotsakos G., Mastoraki S., Papanikolaou I.S., Danias N., Smyrniotis V., et al. Challenging diagnostic and therapeutic modalities for leiomyosarcoma of inferior vena cava. Int J Surg. 2015;13:92–95. doi: 10.1016/j.ijsu.2014.11.051. [DOI] [PubMed] [Google Scholar]
  • 11.Wachtel H., Gupta M., Bartlett E.K., Jackson B.M., Kelz R.R., Karakousis G.C., et al. Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases. Surg Oncol. 2015;24:21–27. doi: 10.1016/j.suronc.2014.10.007. [DOI] [PubMed] [Google Scholar]
  • 12.Cananzi F.C., Mussi C., Bordoni M.G., Marrari A., De Sanctis R., Colombo P., et al. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava. J Surg Oncol. 2016;114:44–49. doi: 10.1002/jso.24244. [DOI] [PubMed] [Google Scholar]

Articles from EJVES Vascular Forum are provided here courtesy of Elsevier

RESOURCES